scholarly journals The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Chao Qin ◽  
Qiang Cao ◽  
Pu Li ◽  
Shangqian Wang ◽  
Jian Wang ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Genetic Variants ◽  
Renal Cell ◽  
Toxic Effects ◽  
Advanced Renal Cell Carcinoma

Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes

Life Sciences ◽  
2021 ◽  
Vol 275 ◽  
pp. 119396
Author(s):  
Yuan-Chin Tsai ◽  
Chao-Yuan Huang ◽  
Yu-Mei Hsueh ◽  
Yu-Ching Fan ◽  
Yu-Cin Fong ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Genetic Variants ◽  
Renal Cell

Association of AXL and PD-L1 expression with clinical outcomes in patients with advanced renal cell carcinoma treated with PD-1 blockade

2021 ◽  
pp. clincanres.0972.2021
Author(s):  
Stéphane Terry ◽  
Cécile Dalban ◽  
Nathalie Rioux Leclercq ◽  
Julien Adam ◽  
Maxime Meylan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma

scholarly journals Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma

Kidney Cancer ◽  
2020 ◽  
Vol 4 (1) ◽  
pp. 29-39
Author(s):  
Nizar M. Tannir ◽  
Thomas Powles ◽  
Bernard Escudier ◽  
Frede Donskov ◽  
Viktor Grünwald ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 3

scholarly journals Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma

Cancer ◽  
2020 ◽  
Vol 126 (S9) ◽  
pp. 2079-2085 ◽  
Author(s):  
Yi Dong ◽  
Zheng Wang ◽  
Xin Lu ◽  
Zhenjie Wu ◽  
Zongqin Zhang ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Bone Metastases ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Renal Cell ◽  
Chinese Patients ◽  
Advanced Renal Cell Carcinoma ◽  
Local Surgery

Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma

2020 ◽  
Vol 18 (1) ◽  
pp. e37-e45 ◽  
Author(s):  
Xiting Cao ◽  
Derek Tang ◽  
Barbara Ratto ◽  
Austin Poole ◽  
Shoba Ravichandran ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Real World ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document